<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_quercetin" title="Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with Ganoderma lucidum Extracts" shortTitle="quercetin" author="Sora Huh, Seulki Lee, Su  Jin Choi, Zhexue Wu, Jae-Han Cho, Lina Kim, Yu  Su Shin, Byung  Woog Kang, Jong  Gwang Kim, Kwanghyeon Liu, Hyosun Cho, Hyojeung Kang" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1420-3049/24/21/3834/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
3.	LS	3.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
This	DT	this
study	NN	study
showed	VBD	show
that	IN	that
the	DT	the
cotreatment	NN	cotreatment
of	IN	of
<hi rend="italic">
G.	NNP	G.
lucidum	NN	lucidum
</hi>
extracts	NNS	extract
(	-LRB-	(
GLE	NNP	GLE
)	-RRB-	)
and	CC	and
quercetin	NN	quercetin
(	-LRB-	(
QCT	NNP	QCT
)	-RRB-	)
exerted	VBD	exert
synergistic	JJ	synergistic
antitumor	NN	antitumor
and	CC	and
antiviral	JJ	antiviral
activities	NNS	activity
against	IN	against
SNU719	NNP	SNU719
EBVaGC	NNP	EBVAGC
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Low	JJ	low
concentrations	NNS	concentration
of	IN	of
the	DT	the
cotreatment	NN	cotreatment
resulted	VBD	result
in	IN	in
both	CC	both
the	DT	the
synergistic	JJ	synergistic
activation	NN	activation
of	IN	of
cytotoxicity	NN	cytotoxicity
in	IN	in
SNU719	NNP	SNU719
cells	NNS	cell
and	CC	and
the	DT	the
suppression	NN	suppression
of	IN	of
tumor	NN	tumor
development	NN	development
in	IN	in
MKN1-EBV	NNP	Mkn1-ebv
xenograft	NN	xenograft
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
The	DT	the
addition	NN	addition
of	IN	of
a	DT	a
low	JJ	low
concentration	NN	concentration
GLE	NNP	GLE
to	IN	to
QCT	NNP	QCT
reinforced	VBD	reinforce
QCT-mediated	VBN	qcT-mediate
cytotoxicity	NN	cytotoxicity
and	CC	and
QCT-mediated	NNP	QCT-mediated
apoptosis	NN	apoptosis
in	IN	in
SNU719	NNP	SNU719
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
the	DT	the
addition	NN	addition
also	RB	also
activated	VBD	activate
the	DT	the
EBV	NNP	EBV
lytic	NN	lytic
gene	NN	gene
promoter	NN	promoter
and	CC	and
upregulated	VBD	upregulate
EBV	NNP	EBV
genes	NNS	gene
.	.	.
</s>
<s type="decl">
Interestingly	RB	interestingly
,	,	,
ganoderic	JJ	ganoderic
acid	NN	acid
A	NNP	A
(	-LRB-	(
GAA	NNP	GAA
)	-RRB-	)
,	,	,
an	DT	a
effective	JJ	effective
molecule	NN	molecule
of	IN	of
GLE	NNP	GLE
also	RB	also
showed	VBD	show
similar	JJ	similar
bioactive	JJ	bioactive
features	NNS	feature
with	IN	with
QCT	NNP	QCT
like	IN	like
GLE	NNP	GLE
.	.	.
</s>
<s type="decl">
The	DT	the
low	JJ	low
concentrations	NNS	concentration
of	IN	of
the	DT	the
GAA	NNP	GAA
and	CC	and
QCT	NNP	QCT
cotreatment	NN	cotreatment
reinforced	VBD	reinforce
QCT-mediated	VBN	qcT-mediate
cytotoxicity	NN	cytotoxicity
and	CC	and
QCT-mediated	JJ	QCT-mediated
apoptosis	NN	apoptosis
in	IN	in
SNU719	NNP	SNU719
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
the	DT	the
cotreatment	NN	cotreatment
activated	VBD	activate
the	DT	the
EBV	NNP	EBV
lytic	NN	lytic
gene	NN	gene
promoter	NN	promoter
and	CC	and
upregulated	VBD	upregulate
EBV	NNP	EBV
genes	NNS	gene
,	,	,
like	IN	like
GLE	NNP	GLE
.	.	.
</s>
</p>
<p>
<s type="decl">
QCT	NNP	QCT
has	VBZ	have
been	VBN	be
shown	VBN	show
to	TO	to
exhibit	VB	exhibit
potential	JJ	potential
anticancer	NN	anticancer
properties	NNS	property
owing	VBG	owe
to	IN	to
its	PRP$	its
antiproliferative	JJ	antiproliferative
,	,	,
growth	NN	growth
factor	NN	factor
suppressive	NN	suppressive
and	CC	and
antioxidant	JJ	antioxidant
effects	NNS	effect
.	.	.
</s>
<s type="sub">
In	IN	in
addition	NN	addition
,	,	,
QCT	NNP	QCT
can	MD	can
induce	VB	induce
apoptosis	NN	apoptosis
,	,	,
where	WRB	where
it	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
to	TO	to
reduce	VB	reduce
the	DT	the
growth	NN	growth
of	IN	of
tumors	NNS	tumor
and	CC	and
inhibit	VB	inhibit
the	DT	the
spread	NN	spread
of	IN	of
malignant	JJ	malignant
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
it	PRP	it
inhibited	VBD	inhibit
chemical	JJ	chemical
carcinogen-induced	JJ	carcinogen-induced
cell	NN	cell
transformation	NN	transformation
,	,	,
which	WDT	which
was	VBD	be
evident	JJ	evident
as	IN	as
cell	NN	cell
viability	NN	viability
decreased	VBD	decrease
,	,	,
ROS	NNP	ROS
generation	NN	generation
and	CC	and
microRNA-21	NN	microRNA-21
elevation	NN	elevation
occurred	VBD	occur
in	IN	in
cancer	NN	cancer
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Besides	IN	besides
its	PRP$	its
antitumor	NN	antitumor
effects	NNS	effect
,	,	,
QCT	NNP	QCT
has	VBZ	have
been	VBN	be
shown	VBN	show
to	TO	to
have	VB	have
antiviral	JJ	antiviral
activity	NN	activity
through	IN	through
its	PRP$	its
anti-infective	JJ	anti-infective
and	CC	and
anti-replicative	JJ	anti-replicative
abilities	NNS	ability
.	.	.
</s>
<s type="decl">
The	DT	the
replication	NN	replication
of	IN	of
herpes	NNS	herpe
viruses	NNS	virus
,	,	,
including	VBG	include
EBV	NNP	EBV
,	,	,
was	VBD	be
found	VBN	find
to	TO	to
be	VB	be
affected	VBN	affect
by	IN	by
QCT	NNP	QCT
.	.	.
</s>
<s type="decl">
EBVaGC	NNP	EBVAGC
exhibits	VBZ	exhibit
mixed	JJ	mixed
characteristics	NNS	characteristic
of	IN	of
both	CC	both
gastric	JJ	gastric
carcinoma	NN	carcinoma
and	CC	and
EBV	NNP	EBV
.	.	.
</s>
<s type="decl">
Apoptosis	NN	apoptosis
and	CC	and
EBV	NNP	EBV
lytic	JJ	lytic
reactivation	NN	reactivation
can	MD	can
control	VB	control
the	DT	the
fate	NN	fate
of	IN	of
EBVaGC	NNP	EBVAGC
cells	NNS	cell
,	,	,
where	WRB	where
antitumor	NN	antitumor
agents	NNS	agent
can	MD	can
induce	VB	induce
apoptosis	NN	apoptosis
and	CC	and
antiviral	JJ	antiviral
agents	NNS	agent
can	MD	can
stimulate	VB	stimulate
EBV	NNP	EBV
lytic	JJ	lytic
reactivation	NN	reactivation
to	TO	to
further	RBR	far
aggravate	VB	aggravate
cell	NN	cell
lysis	NN	lysis
.	.	.
</s>
<s type="decl">
QCT	NNP	QCT
exhibits	VBZ	exhibit
both	CC	both
antitumor	NN	antitumor
and	CC	and
antiviral	JJ	antiviral
activities	NNS	activity
against	IN	against
EBVaGC	NNP	EBVAGC
.	.	.
</s>
<s type="decl">
This	DT	this
dual	JJ	dual
function	NN	function
of	IN	of
QCT	NNP	QCT
is	VBZ	be
likely	JJ	likely
to	TO	to
be	VB	be
synergistic	JJ	synergistic
.	.	.
</s>
<s type="decl">
GLE	NNP	GLE
,	,	,
containing	VBG	contain
polysaccharides	NNS	polysaccharide
and	CC	and
triterpenes	NNS	triterpen
,	,	,
is	VBZ	be
known	VBN	know
to	TO	to
suppress	VB	suppress
the	DT	the
proliferation	NN	proliferation
and	CC	and
metastatic	JJ	metastatic
potential	NN	potential
of	IN	of
breast	NN	breast
cancer	NN	cancer
cells	NNS	cell
by	IN	by
inhibiting	VBG	inhibit
Akt	NNP	Akt
,	,	,
AP-1	NNP	AP-1
and	CC	and
NF-κB	NNP	NF-κB
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
GLE	NNP	GLE
modulated	VBD	modulate
the	DT	the
estrogen	NN	estrogen
receptor	NN	receptor
signaling	NN	signaling
and	CC	and
inhibited	VBD	inhibit
oxidative	JJ	oxidative
stress-induced	NN	stress-induced
invasiveness	NN	invasiveness
of	IN	of
breast	NN	breast
cancer	NN	cancer
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Consistent	JJ	consistent
with	IN	with
the	DT	the
results	NNS	result
of	IN	of
previous	JJ	previous
studies	NNS	study
on	IN	on
breast	NN	breast
cancer	NN	cancer
,	,	,
our	PRP$	our
study	NN	study
showed	VBD	show
that	IN	that
GLE	NNP	GLE
enhanced	VBD	enhance
both	CC	both
QCT-mediated	VBN	qcT-mediate
apoptosis	NN	apoptosis
and	CC	and
EBV-lytic	NN	EBV-lytic
reactivation	NN	reactivation
.	.	.
</s>
<s type="decl">
The	DT	the
effects	NNS	effect
of	IN	of
GLE	NNP	GLE
were	VBD	be
evident	JJ	evident
at	IN	at
low	JJ	low
concentrations	NNS	concentration
of	IN	of
QCT	NNP	QCT
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
QCT	NNP	QCT
also	RB	also
enhanced	VBD	enhance
the	DT	the
GLE-mediated	VBN	gle-mediate
upregulation	NN	upregulation
of	IN	of
the	DT	the
EBV	NNP	EBV
gene	NN	gene
expression	NN	expression
.	.	.
</s>
<s type="decl">
Similarly	RB	similarly
,	,	,
the	DT	the
effects	NNS	effect
of	IN	of
QCT	NNP	QCT
were	VBD	be
evident	JJ	evident
at	IN	at
low	JJ	low
concentrations	NNS	concentration
of	IN	of
GLE	NNP	GLE
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
these	DT	this
results	NNS	result
suggested	VBD	suggest
that	IN	that
GLE	NNP	GLE
enhanced	VBD	enhance
QCT-mediated	NNP	QCT-mediated
apoptosis	NN	apoptosis
,	,	,
whereas	IN	whereas
QCT	NNP	QCT
increased	VBD	increase
GLE-mediated	NNP	GLE-mediated
EBV	NNP	EBV
lytic	JJ	lytic
reactivation	NN	reactivation
.	.	.
</s>
</p>
<p>
<s type="decl">
Mycotherapy	NNP	Mycotherapy
has	VBZ	have
several	JJ	several
benefits	NNS	benefit
,	,	,
where	WRB	where
it	PRP	it
improves	VBZ	improve
the	DT	the
overall	JJ	overall
response	NN	response
rate	NN	rate
during	IN	during
cancer	NN	cancer
treatment	NN	treatment
,	,	,
enhances	VBZ	enhance
immunity	NN	immunity
owing	VBG	owe
to	IN	to
the	DT	the
stimulation	NN	stimulation
of	IN	of
T	NN	T
cell	NN	cell
proliferation	NN	proliferation
and	CC	and
reduces	VBZ	reduce
some	DT	some
chemotherapy-associated	JJ	chemotherapy-associated
adverse	JJ	adverse
events	NNS	event
,	,	,
such	JJ	such
as	IN	as
nausea	NN	nausea
and	CC	and
insomnia	NN	insomnia
.	.	.
</s>
<s type="decl">
Medicinal	JJ	Medicinal
mushrooms	NNS	mushroom
have	VBP	have
mainly	RB	mainly
been	VBN	be
used	VBN	use
in	IN	in
Asian	JJ	Asian
countries	NNS	country
for	IN	for
hundreds	NNS	hundred
of	IN	of
years	NNS	year
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
infectious	JJ	infectious
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
More	RBR	more
recently	RB	recently
,	,	,
they	PRP	they
have	VBP	have
been	VBN	be
used	VBN	use
for	IN	for
cancer	NN	cancer
treatment	NN	treatment
as	IN	as
adjuncts	NNS	adjunct
.	.	.
</s>
<s type="decl">
Importantly	RB	importantly
,	,	,
they	PRP	they
have	VBP	have
an	DT	a
extensive	JJ	extensive
clinical	JJ	clinical
history	NN	history
of	IN	of
safe	JJ	safe
use	NN	use
as	IN	as
single	JJ	single
agents	NNS	agent
or	CC	or
in	IN	in
combination	NN	combination
with	IN	with
chemotherapy	NN	chemotherapy
.	.	.
</s>
<s type="decl">
GLE	NNP	GLE
has	VBZ	have
been	VBN	be
intensively	RB	intensively
combined	VBN	combine
with	IN	with
mycotherapy	NN	mycotherapy
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
broad-spectrum	JJ	broad-spectrum
cancers	NNS	cancer
.	.	.
</s>
<s type="decl">
GLE	NNP	GLE
has	VBZ	have
shown	VBN	show
antitumor	NN	antitumor
activities	NNS	activity
against	IN	against
breast	NN	breast
cancer	NN	cancer
,	,	,
bladder	NN	bladder
cancer	NN	cancer
,	,	,
prostate	NN	prostate
cancer	NN	cancer
,	,	,
colorectal	JJ	colorectal
cancer	NN	cancer
and	CC	and
others	NNS	other
.	.	.
</s>
<s type="decl">
These	DT	this
tumor	NN	tumor
inhibitory	NN	inhibitory
effects	NNS	effect
of	IN	of
GLE	NNP	GLE
were	VBD	be
attributed	VBN	attribute
to	IN	to
the	DT	the
disruption	NN	disruption
of	IN	of
the	DT	the
proliferation	NN	proliferation
and	CC	and
metastasis	NN	metastasis
of	IN	of
cancer	NN	cancer
cells	NNS	cell
.	.	.
</s>
<s type="sub">
However	RB	however
,	,	,
the	DT	the
fact	NN	fact
that	IN	that
EBV	NNP	EBV
is	VBZ	be
the	DT	the
initiator	NN	initiator
of	IN	of
gastric	JJ	gastric
carcinoma	NN	carcinoma
should	MD	should
be	VB	be
considered	VBN	consider
in	IN	in
the	DT	the
treatment	NN	treatment
of	IN	of
EBVaGC	NNP	EBVAGC
.	.	.
</s>
<s type="sub">
EBV	NN	EBV
should	MD	should
be	VB	be
eliminated	VBN	eliminate
to	TO	to
reduce	VB	reduce
the	DT	the
risk	NN	risk
of	IN	of
EBVaGC	NNP	EBVAGC
relapse	NN	relapse
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
QCT	NNP	QCT
strongly	RB	strongly
induced	VBD	induce
EBV	NNP	EBV
lytic	NN	lytic
reactivation	NN	reactivation
.	.	.
</s>
<s type="decl">
The	DT	the
synergistic	JJ	synergistic
effects	NNS	effect
of	IN	of
the	DT	the
GLE	NNP	GLE
and	CC	and
QCT	NNP	QCT
cotreatment	NN	cotreatment
might	MD	might
enhance	VB	enhance
QCT-mediated	JJ	QCT-mediated
apoptosis	NN	apoptosis
and	CC	and
GLE-mediated	NNP	GLE-mediated
EBV	NNP	EBV
lytic	JJ	lytic
reactivation	NN	reactivation
.	.	.
</s>
<s type="sub">
Therefore	RB	therefore
,	,	,
QCT-supplemented	NNP	QCT-supplemented
GLE	NNP	GLE
might	MD	might
be	VB	be
used	VBN	use
as	IN	as
a	DT	a
medicinal	JJ	medicinal
food	NN	food
with	IN	with
a	DT	a
dual	JJ	dual
function	NN	function
as	IN	as
an	DT	a
antitumor	NN	antitumor
and	CC	and
antiviral	JJ	antiviral
agent	NN	agent
for	IN	for
EBVaGC	NNP	EBVAGC
treatment	NN	treatment
.	.	.
</s>
</p>
<p>
<s type="decl">
To	IN	to
the	DT	the
author	NN	author
’s	POS	's
knowledge	NN	knowledge
,	,	,
this	DT	this
is	VBZ	be
the	DT	the
first	JJ	first
study	NN	study
to	TO	to
report	VB	report
that	IN	that
QCT-supplemented	NNP	QCT-supplemented
GLE	NNP	GLE
might	MD	might
be	VB	be
effective	JJ	effective
in	IN	in
treating	VBG	treat
EBVaGC	NNP	EBVAGC
.	.	.
</s>
<s type="decl">
The	DT	the
synergistic	JJ	synergistic
antitumor	NN	antitumor
and	CC	and
antiviral	JJ	antiviral
effects	NNS	effect
were	VBD	be
supported	VBN	support
by	IN	by
both	CC	both
in	IN	in
vivo	NN	vivo
and	CC	and
in	RB	in
vitro	NN	vitro
studies	NNS	study
.	.	.
</s>
<s type="sub">
Hence	RB	hence
,	,	,
the	DT	the
combined	VBN	combine
use	NN	use
of	IN	of
GLE	NNP	GLE
and	CC	and
QCT	NNP	QCT
could	MD	could
be	VB	be
beneficial	JJ	beneficial
in	IN	in
cancer	NN	cancer
treatment	NN	treatment
by	IN	by
alleviating	VBG	alleviate
the	DT	the
toxicity	NN	toxicity
of	IN	of
conventional	JJ	conventional
chemotherapy	NN	chemotherapy
and	CC	and
improving	VBG	improve
the	DT	the
immune	JJ	immune
function	NN	function
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
more	JJR	more
studies	NNS	study
are	VBP	be
still	RB	still
needed	VBN	need
to	TO	to
further	RBR	far
elucidate	VB	elucidate
the	DT	the
molecular	JJ	molecular
mechanisms	NNS	mechanism
of	IN	of
the	DT	the
direct	JJ	direct
antitumor	NN	antitumor
and	CC	and
antiviral	JJ	antiviral
effects	NNS	effect
of	IN	of
QCT-supplemented	NNP	QCT-supplemented
GLE	NNP	GLE
.	.	.
</s>
</p>
</text>